# Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

> **NCT05157269** · PHASE3 · WITHDRAWN · sponsor: **Romark Laboratories L.C.**

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Nitazoxanide
- **DRUG:** Placebo
- **DIETARY_SUPPLEMENT:** Vitamin Super-B Complex

## Key facts

- **NCT ID:** NCT05157269
- **Lead sponsor:** Romark Laboratories L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-08
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2024-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157269, "Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05157269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*